×

Pfizer reports mixed quarter, increases midrange 2017 EPS guidance

7:11 AM ET Tue, 1 Aug 2017

It is essentially a bond, says Barbara Ryan, Barbara Ryan Advisors, talking about Pfizer's struggle to provide shareholders growth. Eventually they will turn to M&A, says Ryan.